CYP17A1 and prostate cancer: In summary, this meta-analysis did not provide evidence of an association between CYP17 T27C polymorphism and prostate cancer risk in a pooled worldwide population, but under the recessive model this polymorphism was significantly associated with prostate cancer among individuals of African descent.